Cargando…

An itchy erythematous papular skin rash as a possible early sign of COVID-19: a case report

BACKGROUND: Several recent studies suggest the possibility of a skin rash being a clinical presentation of coronavirus disease 2019 (COVID-19). The purpose of this case report is to bring attention to skin manifestations in the early stage of COVID-19 in order to support frontline physicians in thei...

Descripción completa

Detalles Bibliográficos
Autores principales: Serafini, Alice, Kurotschka, Peter Konstantin, Bertolani, Mariabeatrice, Riccomi, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649709/
https://www.ncbi.nlm.nih.gov/pubmed/33168054
http://dx.doi.org/10.1186/s13256-020-02538-y
_version_ 1783607376595648512
author Serafini, Alice
Kurotschka, Peter Konstantin
Bertolani, Mariabeatrice
Riccomi, Silvia
author_facet Serafini, Alice
Kurotschka, Peter Konstantin
Bertolani, Mariabeatrice
Riccomi, Silvia
author_sort Serafini, Alice
collection PubMed
description BACKGROUND: Several recent studies suggest the possibility of a skin rash being a clinical presentation of coronavirus disease 2019 (COVID-19). The purpose of this case report is to bring attention to skin manifestations in the early stage of COVID-19 in order to support frontline physicians in their crucial activity of case identification. CASE PRESENTATION: The patient is an Italian 32-year-old female nurse who had several close contacts with multiple patients with COVID-19 as part of her professional workload. On March 13, 2020, the patient developed an itchy, erythematous papular rash (sparing only her face, scalp, and abdomen), which lasted for 10 days. The rash was accompanied by a feeling of general fatigue that gradually worsened over the following days and has continued for 5 months (until the end of July 2020). During the first week of remote assessment carried out by her general practitioner, the patient gradually developed a dry cough, intermittent fever, and diarrhoea and then had a positive test result for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Her skin manifestations disappeared completely 48 days after the onset of the disease, followed by the disappearance of the dry cough. CONCLUSIONS: In light of recent studies, this case report suggests that skin manifestations, when taken into account with other situational factors (such as profession and patient history) should be taken into proper consideration by frontline physicians as possibly being caused by SARS-CoV-2. Early identification of COVID-19 is a key part of the strategy of case detection and case isolation. To enhance this activity, further research is needed to establish frequency, symptoms, signs, and pathogenesis of skin manifestations in patients with COVID-19.
format Online
Article
Text
id pubmed-7649709
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76497092020-11-09 An itchy erythematous papular skin rash as a possible early sign of COVID-19: a case report Serafini, Alice Kurotschka, Peter Konstantin Bertolani, Mariabeatrice Riccomi, Silvia J Med Case Rep Case Report BACKGROUND: Several recent studies suggest the possibility of a skin rash being a clinical presentation of coronavirus disease 2019 (COVID-19). The purpose of this case report is to bring attention to skin manifestations in the early stage of COVID-19 in order to support frontline physicians in their crucial activity of case identification. CASE PRESENTATION: The patient is an Italian 32-year-old female nurse who had several close contacts with multiple patients with COVID-19 as part of her professional workload. On March 13, 2020, the patient developed an itchy, erythematous papular rash (sparing only her face, scalp, and abdomen), which lasted for 10 days. The rash was accompanied by a feeling of general fatigue that gradually worsened over the following days and has continued for 5 months (until the end of July 2020). During the first week of remote assessment carried out by her general practitioner, the patient gradually developed a dry cough, intermittent fever, and diarrhoea and then had a positive test result for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Her skin manifestations disappeared completely 48 days after the onset of the disease, followed by the disappearance of the dry cough. CONCLUSIONS: In light of recent studies, this case report suggests that skin manifestations, when taken into account with other situational factors (such as profession and patient history) should be taken into proper consideration by frontline physicians as possibly being caused by SARS-CoV-2. Early identification of COVID-19 is a key part of the strategy of case detection and case isolation. To enhance this activity, further research is needed to establish frequency, symptoms, signs, and pathogenesis of skin manifestations in patients with COVID-19. BioMed Central 2020-11-09 /pmc/articles/PMC7649709/ /pubmed/33168054 http://dx.doi.org/10.1186/s13256-020-02538-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Serafini, Alice
Kurotschka, Peter Konstantin
Bertolani, Mariabeatrice
Riccomi, Silvia
An itchy erythematous papular skin rash as a possible early sign of COVID-19: a case report
title An itchy erythematous papular skin rash as a possible early sign of COVID-19: a case report
title_full An itchy erythematous papular skin rash as a possible early sign of COVID-19: a case report
title_fullStr An itchy erythematous papular skin rash as a possible early sign of COVID-19: a case report
title_full_unstemmed An itchy erythematous papular skin rash as a possible early sign of COVID-19: a case report
title_short An itchy erythematous papular skin rash as a possible early sign of COVID-19: a case report
title_sort itchy erythematous papular skin rash as a possible early sign of covid-19: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649709/
https://www.ncbi.nlm.nih.gov/pubmed/33168054
http://dx.doi.org/10.1186/s13256-020-02538-y
work_keys_str_mv AT serafinialice anitchyerythematouspapularskinrashasapossibleearlysignofcovid19acasereport
AT kurotschkapeterkonstantin anitchyerythematouspapularskinrashasapossibleearlysignofcovid19acasereport
AT bertolanimariabeatrice anitchyerythematouspapularskinrashasapossibleearlysignofcovid19acasereport
AT riccomisilvia anitchyerythematouspapularskinrashasapossibleearlysignofcovid19acasereport
AT serafinialice itchyerythematouspapularskinrashasapossibleearlysignofcovid19acasereport
AT kurotschkapeterkonstantin itchyerythematouspapularskinrashasapossibleearlysignofcovid19acasereport
AT bertolanimariabeatrice itchyerythematouspapularskinrashasapossibleearlysignofcovid19acasereport
AT riccomisilvia itchyerythematouspapularskinrashasapossibleearlysignofcovid19acasereport